PAVmed Capital Expenditures (CapEx) Growth & History (PAVM)

PAVmed's capital expenditures (capex) was $31,000 for fiscal 2025.

View full PAVmed company overview

PAVmed annual capital expenditures (capex) history

PAVmed annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$31,000−$24,000−43.64%
20242024-12-31$55,000−$187,000−77.27%
20232023-12-31$242,000−$1.3M−84.29%
20222022-12-31$1.5M$71,000+4.83%
20212021-12-31$1.5M$1.4M+2570.91%
20202020-12-31$55,000$28,000+103.70%
20192019-12-31$27,000$391+1.47%
20182018-12-31$26,609$21,308+401.96%
20172017-12-31$5,301−$16,492−75.68%
20162016-12-31$21,793

PAVmed capital expenditures (capex) trends

Over the last five fiscal years, PAVmed's capital expenditures (capex) decreased from $55,000 to $31,000, a change of −$24,000. The latest reported quarter, Q2 2026, shows $13,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review PAVmed source filings ↗

Community posts

It’s quiet here.

No posts about PAVM yet. Start the conversation.

Write the first post